ArticleScientific reports2026
Interaction between oxygen saturation and renal function on 30-day mortality in emergency department patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging evidence suggests that bidirectional lung–kidney crosstalk may influence outcomes, but this has not been systematically evaluated in unselected emergency department populations. We therefore examined the association between peripheral oxygen saturation (SpO₂), estimated glomerular filtration rate (eGFR), and 30‑day mortality, and tested whether the prognostic association of oxygenation with mortality differs across levels of kidney function (and vice versa), using an SpO₂×eGFR interaction term to model effect modification We analyzed 12,651 adults with complete data on SpO₂, creatinine-derived eGFR, lactate, C-reactive protein (CRP), RETTS triage, and prespecified covariates from the Skåne Emergency Medicine (Skåne 17/18) cohort (2017–2018). We fitted multivariable logistic regression models including SpO₂ and eGFR (Model 1) and then added an SpO₂×eGFR interaction term (Model 2). Nested models were compared using a likelihood-ratio test, and discrimination was compared using AUROC (DeLong test) based on model-predicted probabilities. In a predefined subgroup with arterial blood gases (n = 3,068), we evaluated eGFR in relation to PaO₂/FiO₂ (P/F). In the full cohort, SpO₂ and eGFR were significantly correlated. Adding the SpO₂×eGFR interaction term improved model fit versus the main-effects model (LRT ΔDeviance = 15.77, p = 7.17 × 10⁻⁵), but discrimination was essentially unchanged (AUROC 0.744 vs. 0.745; ΔAUROC 0.0009; 95% CI − 0.00227 to 0.00046; DeLong p = 0.193). In the interaction model, higher SpO₂ and eGFR were associated with lower 30-day mortality (OR 0.81, 95% CI 0.77–0.85; OR 0.85, 95% CI 0.80–0.91), and the interaction term indicated stronger protection when both were higher (OR 0.90, 95% CI 0.86–0.95). Exploratory subgroup analyses suggested the interaction effect was most pronounced among patients presenting with chest pain. SpO₂ and eGFR showed evidence of interaction in relation to 30-day mortality. Although adding the interaction term improved model fit, it did not meaningfully improve discrimination compared to main model (without interaction). This suggests that, in unselected ED populations, measuring and interpreting SpO₂ and eGFR remains clinically useful, whereas explicitly modeling their interaction is unlikely to add substantial predictive benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.